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O B J E C T I V E S We hypothesized that the extent of aortic atheroma of the entire thoracic aorta,
determined by pre-operative multidetector-row computed tomographic angiography (MDCTA), is
associated with long-term mortality following nonaortic cardiothoracic surgery.
B A C KG ROUND In patients evaluated for cardiothoracic surgery, presence of severe aortic
atheroma is associated with adverse short- and long-term post-operative outcome. However, the
relationship between aortic plaque burden and mortality remains unknown.
METHOD S We reviewed clinical and imaging data from all patients who underwent electrocardiographic-
gated contrast-enhancedMDCTA prior to coronary bypass or valvular heart surgery at our institution between
2002 and 2008. MDCTA studies were analyzed for thickness and circumferential extent of aortic atheroma in
5 segments of the thoracic aorta. A semiquantitative total plaque-burden score (TPBS) was calculated by
assigning a score of 1 to 3 to plaque thickness and to circumferential plaque extent. When combined, this
resulted in a score of 0 to 6 for each of the 5 segments and, hence, an overall score from 0 to 30. The primary
end point was all-cause mortality during long-term follow-up.
R E S U L T S A total of 862 patients (71% men, 67.8 years) were included and followed over a mean
period of 25  16 months. The mean TPBS was 8.6 (SD: 6.0). The TPBS was a statistically signiﬁcant
predictor of mortality (p  0.0001) while controlling for baseline demographics, cardiovascular risk
factors, and type of surgery including reoperative status. The estimated hazard ratio for TPBS was 1.08
(95% conﬁdence interval: 1.045 to 1.12). Other independent predictors of mortality were glomerular
ﬁltration rate (p  0.015), type of surgery (p  0.007), and peripheral artery disease (p  0.03).
CONC L U S I O N S Extent of thoracic aortic atheroma burden is independently associated with increased
long-term mortality in patients following cardiothoracic surgery. Although our data do not provide deﬁnitive
evidence, they suggest a relationship to the systemic atherosclerotic disease process and, therefore, have
important implications for secondary prevention in post-operative rehabilitation programs. (J Am Coll
Cardiol Img 2010;3:1020–9) © 2010 by the American College of Cardiology Foundation
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1021n population-based studies of asymptomatic indi-
viduals and persons with suspected coronary artery
disease, calcified aortic atheroma has been shown
to be associated with increased risk of major
ardiovascular events (1,2).
In patients evaluated for cardiothoracic surgery,
alcified and noncalcified aortic atheroma has been
ssessed using intraoperative epiaortic ultrasound
nd transesophageal echocardiography. In these
tudies, the focal presence and severity of atheroma
t the most diseased aortic segment has been
stablished as a predictor of post-operative compli-
ations, as well of adverse long-term outcome (3–6).
owever, it remains unknown whether the extent
nd distribution of atheroma burden along the
ntire aorta is related to mortality.
Multidetector-row computed tomographic an-
iography (MDCTA) of the chest and aorta, per-
ormed prior to cardiothoracic surgery for the iden-
ification of high-risk anatomic features, allows
ssessment of aortic plaque burden in the entire
horacic aorta in a semiquantitative fashion (7).
We hypothesized that the extent and location of
ortic atheroma, determined by pre-operative
DCTA, is associated with long-term mortality
ollowing nonaortic cardiothoracic surgery.
E T H O D S
atients. We screened the electronic medical record
f 10,300 patients who underwent cardiothoracic
urgery at our institution between 2002 and 2008.
e identified patients who underwent coronary
rtery bypass graft (CABG) surgery, valvular sur-
ery, or combined bypass and valvular surgery, but
xcluded patients with concomitant aortic surgery.
ut of these, 870 patients had pre-operative
ontrast-enhanced MDCTA. The studies were
erformed for evaluation of thoracic and aortic
natomy and/or bypass graft location in the context
f surgical planning (7). A total of 8 patients with
ncomplete clinical data were excluded. Therefore,
he final study population included 862 patients.
pproval was obtained from the institutional review
oard at our institution, with waiver of individual
onsent.
linical records. Baseline demographics, past medi-
al history, and medication use were prospectively
ecorded using the Cardiovascular Information
egistry at our institution. Height and weight were
easured directly, and body mass index was calcu-
ated as weight in kilograms divided by the square
f height in meters. Standard demographic data and aistory of smoking (any prior or current history of
moking), diabetes (patient on insulin or oral hy-
oglycemic medications, or prescribed a diabetic
iet), hypertension (resting blood pressure140/90
m Hg, or use of antihypertensive medications),
oronary artery disease (presence of at least 1
oronary artery stenosis 50% diameter stenosis on
oronary angiography), prior myocardial infarction
MI), renal function (glomerular filtration rate
GFR]), peripheral arterial disease (PAD), stroke,
nd congestive heart failure were recorded. Type of
urgery and reoperative status was also recorded.
rimary clinical end points. The primary end point
as all-cause mortality during long-term follow-up.
ortality was defined as death of the
atient during follow-up and recorded in
onths after cardiothoracic surgery, based
n the Social Security Death Index (8,9).
DCTA. SCAN ACQUISITION. The pre-
perative scans were performed on multi-
le MDCTA scanner systems (Sensation
6, Sensation 64, and Definition dual-
ource, Siemens Medical Solutions, Erlan-
en, Germany; Brilliance 40, Brilliance
4, and iCT 256, Philips Medical, Best,
he Netherlands). Spiral imaging with ret-
ospective electrocardiographic gating was
erformed following the administration of
onionic contrast material via an antecu-
ital vein. The MDCTA protocols for the
ncluded indications shared the same
raniocaudal coverage (thoracic inlet to
iaphragm), but reconstructed slice thick-
ess varied from 1 mm to 3 mm (80% with
-mm, 15% with 2-mm, and 5% with
-mm slice thickness). These protocols are
ssociated with estimated effective radia-
ion doses averaging 12 mSv.
ATA ANALYSIS. Two physicians, blinded
o clinical data and surgical history, analyzed the
mages. Image analysis was performed on a Siemens
eonardo Workstation (Siemens Medical Solu-
ions). Axial images were initially reviewed. Win-
ow settings were optimized to best differentiate
umen from vessel wall and minimize calcium
looming artifact. Subsequent measurements were
erformed in double-oblique cross-sectional images
fter multiplanar reconstruction along the aortic
enterline, using an electronic caliper (Fig. 1, On-
ine Appendix).
The thoracic aorta was divided into 5 segments
Fig. 2): 1) the “Aortic Root,” from the aortic
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1022ng Aorta,” between the sinotubular junction and
he origin of the innominate artery; 3) the “Aortic
rch,” between the innominate artery and includ-
ng the isthmus; 4) the “Arch Branch Vessel Ori-
Figure 1. Measurement of Plaque Thickness and Circumferentia
The upper panels show a relatively normal vessel wall. The thickne
raphy (CT) spatial resolution. Therefore, a normal wall is not well de
atherosclerotic changes of the vessels wall. Maximal plaque thickne
vessel wall.
Segments of the Aorta Included in the TPBS
ic aorta was divided into 5 segments to deﬁne the total plaque
re (TPBS): 1) Aortic Root; 2) Ascending Aorta; 3) Aortic Arch; 4)a
ranch Vessel Origins; and 5) Descending Aorta.ins,” defined as the ostia and the proximal 10 mm
f the proximal vessel; and 5) the “Descending
orta,” between the isthmus and the diaphragm.
In each segment, the presence, thickness, circum-
erential extent, and type of atheroma were evalu-
ted (5,10) (Fig. 3, Table 1). Presence of plaque was
efined as visible thickening of the aortic wall.
aximal plaque thickness and the maximal circum-
erential extent of atheroma were measured in each
egment using an electronic caliper. The type of
ortic atheromatous plaque was classified as calci-
ed or noncalcified.
otal plaque-burden score. In order to semiquanti-
atively describe the overall extent and distribution
f plaque, we defined a total plaque-burden score
TPBS) by combining plaque thickness and circum-
erential extent in each of the 5 aortic segments
Table 1).
A score of 1 to 3 was assigned based on plaque
hickness (0  no plaque, 1  mild [3 mm], 2 
oderate [3 to 5 mm], and 3  severe [5 mm])
5). Similarly, a score of 1 to 3 was used to describe
ircumferential plaque extent (0  no plaque, 1 
ild [1/3 circumferential diameter], 2  moder-
tent
f about 0.5 mm is in the range of the minimal computed tomog-
d with CT. The lower panels show eccentric, partially calciﬁed
5 mm, and it occupies about 1/3 of the circumference of thel Ex
ss o
ﬁne
ss isFigure 2.
The thorac
burden scote [1/3 to 2/3 circumferential diameter], and 3 
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1023evere [2/3 circumferential diameter]) (10).
hen combined, this resulted in a score of 0 to 6
or each of the 5 segments and, hence, an overall
core from 0 to 30.
Interobserver and intraobserver analysis for the
PBS was performed in a subset of 30 randomly
hosen cases.
tatistical analysis. Descriptive statistics for baseline
emographics and other clinical variables are re-
orded as mean SD (minimal and maximal value)
or continuous variables and percentage for categor-
cal variables. Baseline characteristics were com-
ared among the tertiles of the TPBS using chi-
quare and Kruskal-Wallis tests (for categorical
Figure 3. Example of the Calculation of the TPBS
This ﬁgure shows an example of the calculation of the total plaque
Table 1. Descriptors of Aortic Atheroma Burden
Atheroma thickness
0 Absent
1  mild 3 mm
2  moderate 3–5 mm
3  severe 5 mm
Atheroma circumferential extent
0 Absent
1  mild 1/3 circumferential aortic
diameter
2  moderate 1/3–2/3 circumferential aortic
diameter
3  severe 2/3 circumferential aortica
diameterariables) and 1-way analysis of variance (ANOVA)
for continuous variables).
Thirteen clinical and surgical covariates (includ-
ng TPBS), considered potential predictors of long-
erm mortality, were assessed using Cox propor-
ional hazards regression, with Wald chi-square
ests assessing the statistical significance of each
ndependent variable (software: PROC PHREG,
AS version 9.2, SAS Institute, Cary, North Caro-
ina). Hazard ratios (HRs) with their associated
5% confidence intervals (CIs) were presented for
hose predictors found to be significantly associated
ith long-term mortality. This initial analysis eval-
ated the association of overall TPBS with mortal-
ty, without regard to the distribution of plaque
urden among the 5 aortic segments. The relation-
hips between plaque distribution and long-term
ortality were specifically analyzed in subsequent,
eparate Cox models, controlling for the same set of
ovariates that were included in the initial Cox
odel that assessed the relationship between overall
PBS and long-term mortality.
Interobserver and intraobserver variability with re-
pect to TPBS were described by the mean difference
etween the 2 readers and between 2 readings of a
ingle observer. In addition, 95% CIs were reported
or the mean difference between readers and between
eadings within readers. The Bland-Altman limits of
den score (TPBS) of the thoracic aorta.greement, which are generally expected to include
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10245% of all differences from the same general popula-
ion, were also calculated (11).
E S U L T S
he final statistical analysis included 862 patients.
he mean duration of follow-up was 25  16
range 0 to 80) months.
aseline demographics. Baseline demographics, car-
iovascular risk factors, and types of surgery of the
atient population separated by tertiles of total
laque score are shown in Table 2. There are
tatistically significant differences of several charac-
eristics among tertiles of plaque score. Specifically,
ge (p  0.0001), total cholesterol (p  0.0003),
ew York Heart Association functional class (p 
.0001), frequency of hypertension (p  0.0001),
iabetes (p 0.0003), smoking (p 0.0002), PAD
p  0.0001), history of MI (p  0.0001), and
eoperative surgery (p 0.0001), increased between
Table 2. Baseline Characteristics in Tertiles of TPBS
TPBS
1st Tertile*
(n  295)
Age (yrs) 59.0 (13.4) [19, 86] 7
Male sex 207 (70.2%)
Race, Caucasian 263 (89.2%)
BMI (kg/m2) 28.9 (5.9) [14.4, 61.6] 2
GFR (ml/min) 74.3 (24.4) [3.8, 216.6] 6
Hypertension 176 (59.7%)
Diabetes 92 (31.2%)
Smoking 143 (48.5%)
Total cholesterol 171.1 (43.2) [87, 349] 15
LVEF (echo) 50.5 (10.7) [10, 70] 5
PAD 35 (11.9%)
History of MI 69 (23.4%)
Surgery type
CABG 63 (21.4%)
VALV 157 (53.2%)
Both 75 (25.4%)
Reoperative surgery 146 (49.5%)
Emergency surgery 0 (0%)
Pre-operative beta-blocker 142 (48.1%)
Pre-operative ACE 98 (33.2%)
Pre-operative aspirin 147 (49.8%)
NYHA functional class
0 50 (17.0%)
1 45 (15.3%)
2 146 (49.5%)
3 49 (16.6%)
4 5 (1.7%)
Values are expressed as mean (SD) [minimum, maximum], or n (%). *Approxima
5 to 11 (n  282); 3  TPBS 11–30 (n  285). †Chi-square, ‡F-test; and #K
ACE  angiotensin-converting enzyme; BMI  body mass index; CABG  cor
ejection fraction; MI  myocardial infarction; NYHA  New York Heart Associa
valvular.ertiles. GFR (p  0.0001) decreased between
ertiles (p values are based on chi-square tests for
ategorical variables and 1-way ANOVA for con-
inuous variables).
laque extent, distribution, and composition. Out of
he 862 patients, 127 (15%) had no aortic plaque
TPBS  0) and 735 (85%) had aortic plaque
TPBS  0).
Of the 735 patients with aortic plaque (i.e.,
PBS  0), 10 (1.4%) had only noncalcified
laque. The remaining 725 (98.6%) had evidence of
alcification somewhere along the thoracic aorta;
47 (88.0%) had only calcified plaque, whereas 78
10.6%) had both calcified and noncalcified plaque.
Of the 735 patients with plaque, on the basis of
aximal plaque thickness, 129 of 735 (17.6%)
atients had only mild atheroma (i.e., maximum
laque thickness score of 1 (3 mm) at 1 or several
ortic segments; 306 of 735 (41.6%) patients had
nd Tertile*
(n  282)
3rd Tertile*
(n  285) p Value
(10.2) [36, 90] 74.4 (7.5) [54, 91] 0.0001‡
(72.0%) 200 (70.2%) 0.86†
(91.1%) 259 (90.9%) 0.25†
(5.6) [14.3, 52.4] 28.0 (5.6) [15.2, 59.2] 0.10‡
(24.2) [9.2, 172.0] 62.8 (24.9) [5.9, 287.0] 0.0001‡
(79.8%) 243 (85.3%) 0.0001†
(43.3%) 134 (47.0%) 0.0003†
(47.9%) 180 (63.2%) 0.0002†
(44.0) [22, 411] 156.7 (43.3) [76, 364] 0.0003‡
(11.5) [15, 70] 49.3 (11.7) [15, 70] 0.32‡
(31.2%) 120 (42.1%) 0.0001†
(24.1%) 115 (40.4%) 0.0001†
0.0001†
(22.7%) 74 (26.0%)
(39.7%) 84 (29.5%)
(37.6%) 127 (44.6%)
(68.1%) 227 (79.7%) 0.0001†
(0.7%) 0 (0%) 0.13†
(52.5%) 160 (56.1%) 0.15†
(35.5%) 121 (42.5%) 0.057†
(58.5%) 155 (54.4%) 0.11†
0.0001#
(19.5%) 30 (10.5%)
(7.8%) 26 (9.1%)
(42.6%) 12 (43.5%)
(24.1%) 87 (30.5%)
(6.0%) 18 (6.3%)
rtiles for TPBS were deﬁned as follows: 1  TPBS  0 to 5 (n  295); 2  TPBS
l-Wallis tests.
y artery bypass graft; GFR  glomerular ﬁltration rate; LVEF  left ventricular
PAD  peripheral artery disease; TPBS  total plaque-burden score; VALV 2
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1025oderate atheroma (i.e., maximum plaque thick-
ess score of 2 (3 to 5 mm) at 1 or several aortic
egments; and 300 of 735 (40.8%) patients had
evere atheroma (i.e., maximum plaque thickness
core of 3 (5 mm) at 1 or several aortic segments).
On the basis of maximal plaque circumferential
xtent, 334 of 735 (45.4%) patients had only mild
theroma (i.e., maximum circumferential extent
core of 1 (1/3) at 1 or several aortic segments;
71 of 735 (36.9%) patients had moderate atheroma
i.e., maximum circumferential extent score of 2
1/3 to 2/3) at 1 or several aortic segments; and 130
f 735 (17.7%) patients had severe atheroma (i.e.,
aximum circumferential extent score of 3 (2/3)
t 1 or several aortic segments).
The mean scores (SD) of plaque thickness in the
ortic root, ascending aorta, aortic arch, branch
essels, and descending aorta were 0.46 (0.69),
.41 (0.70), 1.60 (1.10), 0.87 (1.00), and 1.45
1.05), respectively. The mean scores (SD) of
laque circumferential extent in the aortic root,
scending aorta, aortic arch, branch vessels, and
escending aorta were 0.40 (0.60), 0.35 (0.56),
.15 (0.85), 0.76 (0.89), and 1.15 (0.89),
espectively (Table 3). The mean TPBS was 8.6
6.0) for all patients (Table 3).
nterobserver and intraobserver variability for the
PBS. The interobserver variability for TPBS (n 
9) showed a mean difference between the 2 readers
f 1.0 (SD  2.0), and a median difference of 0
minimum, maximum differences: 6, 3).
eader 2 tended to assign a higher TPBS than
eader 1 (p  0.008, signed rank test); however,
0% of all absolute differences were 2. The 95%
I for the mean difference between readers in our
ample was (1.76 to 0.24). The Bland-Altman
imits of agreement were (5, 3) (11).
The intraobserver variability for TPBS (n  30)
howed a mean difference between the 2 readings of
single observer to be 0.17 (SD  1.18), and a
edian difference of 0 (minimum, maximum dif-
erences: 2, 2). The first and second readings
ere equally likely to yield a higher TPBS (p 
.52, signed rank test), and 50% of all absolute
Table 3. Plaque Extent and Distribution
All 1
Total plaque score 8.6 (6.0) 0.86 (1.27)
Plaque thickness 4.79 (3.32) 0.46 (0.69)
Circumferential extent 3.80 (2.81) 0.40 (0.60)Values are expressed as mean (SD). Segment: 1  aortic root; 2  ascending aortaifferences were 1 or less. The 95% CI for the mean
ifference was (0.61 to 0.27). The Bland-
ltman limits of agreement for intrareader differ-
nces were (2.53, 2.19).
ong-term all-cause mortality. Among all patients,
here were a total of 119 confirmed deaths at any
ime point over the length of the study period. Of
hese, 29 (24%) were observed in the first 30 days.
Survival rates were examined in tertiles of TPBS
total N  852, 10 cases excluded due to missing
ata; first tertile TPBS  0 to 5 [n  293], second
ertile 5 to 11 [n  277], and third tertile 11
n  282]). Three-year survival estimates based on
roduct-Limit (Kaplan-Meier) were: Tertile 1 
4.9% (SE  0.017), Tertile 2  82.8% (SE 
.028), and Tertile 3  75.1% (SE  0.035). The
TPBS tertiles were statistically significantly dif-
erent with respect to overall survival (p  0.0001,
og-rank test) (Fig. 4).
elationship of TPBS and long-termmortality. Table 4
hows those predictors significantly associated with
ong-term mortality in univariate and multivariate
nalysis.
The TPBS was a statistically significant predictor
f mortality (p  0.0001) while controlling for sex,
ace, age, BMI, GFR, PAD, hypertension, diabetes
ellitus, smoking, history of MI, echocardio-
raphic ejection fraction, reoperative surgery, and
urgery type. The estimated HR for TPBS was 1.08
95% CI: 1.04 to 1.12), indicating that for every
-unit increase in TPBS, with all other variables
xed, the risk of mortality increased by 8%. Within
he 95% CI, the increased risk of mortality corre-
ponding to any 1-U increase in TPBS lies between
.5% and 12%.
GFR and history of PAD were also statistically
ignificant independent predictors of mortality (p
.015 and p  0.03, respectively), with HRs of
.989 (95% CI: 0.980 to 0.998) and 1.54 (1.05 to
.27), respectively. The fourth statistically signifi-
ant predictor of mortality was type of surgery (p 
.007). Combined CABG and valvular surgery had
he highest risk, followed by valvular surgery alone,
Segments
2 3 4 5
.76 (1.23) 2.75 (1.85) 1.64 (1.85) 2.59 (1.88)
.41 (0.70) 1.60 (1.10) 0.87 (1.00) 1.45 (1.05)
.35 (0.56) 1.15 (0.85) 0.76 (0.89) 1.15 (0.89)0
0
0; 3  aortic arch; 4  arch branch vessel origin; and 5  descending aorta.
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1026nd CABG (valvular surgery alone was the refer-
nce level in a trichotomous surgery variable).
nﬂuence of plaque location. In order to examine the
nfluence of plaque location, we divided the aorta
nto an ascending part (root to arch, segments 1 to
) and a descending part (descending aorta, seg-
ent 5). Ninety patients had plaque only in the
scending part, 34 patients had plaque only in the
escending part, 611 had plaque in both the as-
ending and descending part of the aorta, and 127
ad no plaque in either portion. We calculated the
laque burden score separately for the ascending
art (A-TPBS) and descending part (D-TPBS).
he mean (SD) A-TPBS and mean (SD) D-TPBS
ere 5.97 (4.62) and 2.60 (1.88), respectively.
here was a strong correlation between the ascend-
ng and descending total plaque burden (r 
0.66).
Both A-TPBS (p  0.0001; HR: 1.10) and
-TPBS (p  0.002; HR: 1.22) were significant
redictors of long-term mortality in the absence of
he other (but controlling for the full set of other
ovariates). When A-TPBS and D-TPBS were
oth included in a single model (with the other
ovariates), A-TPBS remained significant (p 
.0007; HR: 1.09), but D-TPBS lost statistical
ignificance (p  0.38). In all 3 of these Cox
roportional hazards regression models, GFR,
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Figure 4. Kaplan-Meier Analysis of Survival
Kaplan-Meier analysis of survival, according to tertiles of atherosclerDA, and surgery type were also significant predic- bors of long-term mortality (p  0.05), whereas all
ther covariates were not significant (p  0.10).
I S C U S S I O N
ur data demonstrate an independent relationship be-
ween the extent of thoracic aortic atheroma burden and
ong-term mortality in patients after cardiothoracic sur-
ery. Specifically, a semiquantitative TPBS was a highly
ignificant predictor of long-term mortality, after con-
rolling for baseline demographics, cardiovascular risk
actors, and types of surgery (TPBS: p  0.0001; HR:
.08). Other independent predictors of mortality were
FR, PAD, and type of surgery.
Previous ultrasound studies in similar patient
opulations have demonstrated that focal presence
nd severity of atheroma, of the visualized (ascend-
ng) aorta, was a predictor of post-operative adverse
vents and long-term mortality (3–6). In these
tudies, the HRs for presence of severe plaque are
omparable to our data, previous imaging studies in
onsurgical populations, and clinical data (12,13).
lso, similar to previous studies (6), the survival
urves in our data (Fig. 4) separate early and
ncreasingly diverge over time, suggesting early and
ustained risk with increasing severity of aortic
theroma.
However, previous imaging studies have been limited
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score (tertile 1, 2, and 3: n  293, 277, and 282, respectively).Ti
30y the fact that presence and severity of atheroma was
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1027ased on focal maximal plaque thickness at the most
iseased segment of the examined (ascending) aorta.
herefore, the pathophysiologic mechanisms underlying
he relationship between atheroma and mortality remains
ncompletely understood. One explanation, based on the
bservation of perioperative events, invokes a dominant
ole of embolic complications, in particular in the context
f manipulations of the aorta during surgery. An alter-
ative hypothesis suggests a more systemic effect of the
iffuse atherosclerotic disease process, with aortic plaque
urden a marker of atherosclerotic disease and compli-
ations in other vascular regions.
The semiquantitative description of extent and
istribution of atheroma along the entire thoracic
orta in our data provides further insights. Impor-
antly, the relationship of plaque extent to mortality
as independent of distribution along the aorta,
hich is evidence that mortality is related to the
ystemic atherosclerotic disease process rather than
ocal (embolic) complications alone. This is further
upported by recent studies in the carotid circulation
nd previous data describing a relationship between
Table 4. Predictors of All-Cause Mortality
Analysis Variable
Univariate
TPBS
GFR
Surgery type
Age
Gender
HTN
History of PAD
Race‡
Diabetes mellitus
Hypercholesterolemia†
BMI†
Smoking
History of MI
Echo EF
Reoperative status
Emergency surgery†
Multivariate
TPBS
GFR
PAD
Surgery type
*These hazard ratios refer to the risk of mortality for each surgery type compared
association with long-term mortality was not found to be signiﬁcant, were exclud
of missing values associated with each (nonsigniﬁcant) predictor. ‡Race was m
Caucasian, other, unknown. §These hazard ratios refer to the risk of mortality fo
CI  conﬁdence interval; EF  ejection fraction; HTN  hypertension; NS  noronary and aortic calcification (14,15). iOur data demonstrate that thoracic aortic athero-
clerosis is a marker of atherosclerotic events and
ortality after cardiothoracic surgery. It is an attrac-
ive hypothesis that this relationship is not limited to
atients after surgery, but describes general atheroscle-
otic disease patterns of the aorta, with impact for
revention of cardiovascular events. This requires
urther evaluation in nonsurgical patient populations.
Recent data from patients evaluated for transcath-
ter aortic valve implantation, a population with very
igh mortality, reveal extensive atherosclerotic disease
f the aorta (16). On the other extreme of the
pectrum, data in population-based asymptomatic in-
ividuals, derived from noncontrast-enhanced CT
tudies, show a relationship between calcified aortic
theroma (aortic calcium scoring) with cardiovascular
isk factors (17) and all-cause mortality, independent
f conventional cardiovascular disease risk factors (18).
owever, although in a recent paper both increasing
oronary artery calcification (CAC) and thoracic aor-
ic calcification (TAC) were significantly associated
ith future cardiovascular events, only CAC was an
p Value Hazard Ratio (95% CI)
 0.0001 1.106 (1.075–1.138)
 0.0001 0.980 (0.972–0.989)
 0.0001 Combined: 1.93 (1.29–2.88)*
CABG: 0.65 (0.36–1.18)*
 0.0001 1.042 (1.024–1.061)
0.016 Male: 0.634 (0.44–0.92)
0.014 No HTN: 0.54 (0.33–0.88)
0.0006 1.89 (1.31–2.73)
0.28 NS
0.14 NS
0.36 NS
 0.9 NS
0.51 NS
0.49 NS
0.07 NS
0.57 NS
0.98 NS
 0.0001 1.08 (1.04–1.12)
0.01 0.989 (0.980–0.998)
0.03 1.54 (1.05–2.27)
0.01 Combined: 1.44 (0.94–2.19)§
CABG: 0.62 (0.33–1.16)§
e risk of mortality for valvular surgery alone. †These variables, whose univariate
om subsequent Cox regression modeling due to the unacceptably high number
led as a categorical variable with the following values: Asian, black, Hispanic,
ch surgery type compared with the risk of mortality for valvular surgery alone.
igniﬁcant; other abbreviations as in Table 2.to th
ed fr
ode
r eandependent predictor, whereas TAC did not add
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1028ignificant predictive power to either the Framingham
isk Score or CAC (15). Comparison of calcified and
oncalcified plaque burden is difficult because the
elationship between calcified and noncalcified plaque
s incompletely understood (19).
Together, these results identify the extent of tho-
acic atheroma burden as a risk factor for adverse
ong-term outcome after cardiothoracic surgery. Al-
hough our data do not provide definitive evidence, it
uggests a relationship to the systemic atherosclerotic
isease process and, therefore, has important implica-
ions for secondary prevention in post-operative reha-
ilitation programs. In this context of secondary pre-
ention, it is interesting that previous MDCTA and
agnetic resonance imaging studies have shown the
otential reversibility of thoracic aortic plaque pro-
ression by aggressive risk-factor modification
20,21).
tudy limitations. The primary outcome in the cur-
ent study was all-cause mortality, which was assessed
sing the Social Security Death Index. Despite limi-
ations, this approach has been shown to be highly
pecific and unbiased (10,11).
MDCTA has high sensitivity, specificity, and over-
ll accuracy for the identification of severe aortic
theroma (22). However, quantification is limited by
alcium blooming artifacts, leading to the overestima-
ion of calcified plaque.
Most patient had calcified plaque, and the number
f individuals with only noncalcified plaque of the
ntire thoracic aorta was low (n  10), limiting
tatistical analysis. Within these limitations, our data
id not demonstrate a significant interaction between
he TPBS and plaque calcification. Due to statistical
ollinearity between total plaque burdens in the as-
ending and descending aorta, conclusions about in-
ependent role of plaque in the ascending and de-
cending aorta are limited.
There is an established correlation between TACangina pectoris patients: association 1997;28:36 –9.e reliably determined from contrast-enhanced im-
ges, and this information is therefore not available for
ur patients. Other aortic plaque characteristics and
laque composition may have an impact on outcome
4,14), but assessment is limited with MDCTA.
An inherent selection bias may exist in our
ata, because performance of a contrast-enhanced
DCTA examination excludes patients with
nown advanced renal disease. These patients
ay represent a particularly high-risk group.
lso, our patient population included almost
xclusively elective surgical indications, because
atients that undergo emergent nonaortic surgery
ypically do not have a prior CT scan.
Our data offer initial “proof of concept” for the
se of TPBS as a risk marker for long-term
ortality in patients with cardiovascular disease.
urther assessment of TPBS should involve sev-
ral phases, including: prospective validation in
ndependent populations; documentation of in-
remental information when added to standard
isk markers; assessment of impact on patient
anagement and outcomes; and cost effectiveness
23). This is particular true for imaging markers,
hich are often associated with high cost and, in
he case of CT, with radiation exposure (24).
O N C L U S I O N S
xtent of thoracic aortic atheroma burden is asso-
iated with increased long-term mortality in pa-
ients following cardiothoracic surgery. These data
ave implications for pre-operative risk assessment.
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